Lifeward Ltd. announced on May 8, 2025, the completion of its three-year research program with the Israeli Human-Robot Interaction Consortium. The program explored how artificial intelligence (AI) could be utilized with future generations of its ReWalk Personal Exoskeleton.
Through this collaboration, Lifeward successfully demonstrated a proof-of-concept prototype that integrated advanced sensing technologies and AI. This prototype enabled autonomous decision-making to adapt to different use environments, aiming to improve exoskeleton device usability.
The research signals Lifeward's commitment to leveraging cutting-edge technology to enhance product performance and user experience. The goal is to provide exoskeletons that anticipate user intent, making the systems easier and more natural to use, thereby maintaining a competitive edge.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.